NULOJIX®

(Belatacept)

Documentation

Patented
Approved 2011
FDA Letter
FDA Label
Full Sequence

Brief Summary

Function Type: Antagonist
Target: CD80 CD86
Indication Category: Transplants

Approved Indications

Detailed Summary

Side Effects

References

Wikipedia
Drugs.com
FDA